Wedbush Downgrades iTeos Therapeutics (ITOS) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. JBLU
3. CDNS
4. META
5. ANT
6. PECO
7. SSD
8. AGYS
9. HWKN
10. INTC

Go back to Wedbush Downgrades iTeos Therapeutics (ITOS) to Neutral

iTeos Therapeutics Announces Its Intention to Wind Down Operations

May 28, 2025 8:30 AM EDT

- Board of Directors intends to cease operations

- Company to focus efforts on selecting best path to deliver near-term value to shareholders

- Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1

WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the intention to wind down its operations... More